---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-019716"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T08:35:32.517735+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences stockholders elect Amoroso and Germano as Class I directors

## Summary
- 74,030,582 shares (66% of outstanding) present at May 4, 2023 annual meeting.
- Michael Amoroso elected with 40,370,180 votes for; 12,559,294 withheld.
- Geno Germano elected with 38,629,199 votes for; 14,300,275 withheld.
- Ratification of Deloitte & Touche as auditor approved: 72,281,763 for, 1,690,384 against.

## SEC filing metadata
- accession: 0000950170-23-019716
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017023019716/0000950170-23-019716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017023019716/dtil-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-019716
- JSON: https://secwatch.observer/filing/0000950170-23-019716.json
- Plain text: https://secwatch.observer/filing/0000950170-23-019716.txt

## Key facts
- Shareholder Votes
  PRECISION BIOSCIENCES INC shareholders approved Election of two Class I directors to serve until the Company's annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. at the 2023-05-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-04
  source text: Item 1 – Election of two Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes Michael Amoroso 40,370,180 12,559,294 21,101,108 Geno Germano 38,629,199 14,300,275 21,101,108
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000095017023019716/0000950170-23-019716-index.htm
- Shareholder Votes
  PRECISION BIOSCIENCES INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. at the 2023-05-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-04
  source text: Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 72,281,763 1,690,384 58,435 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000095017023019716/0000950170-23-019716-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.